Medpal Ai annual ebitda
2022
2023
2024
2025
Medpal Ai EBITDA Growth & History (MPAL)
Medpal Ai's calculated EBITDA was −£2.2M for fiscal 2025.
View full Medpal Ai company overviewMedpal Ai annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-08-31 | −£2.2M | −£2.1M | — |
| 2024 | 2024-08-31 | −£13,359 | £234 | — |
| 2023 | 2023-08-31 | −£13,593 | £22,030 | — |
| 2022 | 2022-08-31 | −£35,623 | — | — |
Medpal Ai ebitda trends
Between the periods ended 2022-08-31 and 2025-08-31, Medpal Ai's ebitda decreased from −£35,623 to −£2.2M, a change of −£2.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medpal Ai source filings ↗Community posts
MedPal reports £1.83m of August New Health revenue; £28m annualised figure is not a forecast
MedPal AI published an August trading update on 7 September 2026. Reported activity New Health generated £1,828,319 revenue from 14,487 orders in August, its first full month of trading after marketing began in July. That compares with £201 ...